Related Experiment Video

Updated: Aug 24, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Antifungal therapy for keratomycoses

Nihal Ganegoda1, Srinivas K Rao

  • 1Medical Research Foundation, Nadu, India.

Expert Opinion on Pharmacotherapy
|April 23, 2004
PubMed

Insights

Fungal keratitis (fungal eye infections) treatment is improving with new drugs and delivery methods. Early diagnosis and molecular techniques are key for managing these serious corneal infections.

Area of Science:

  • Ophthalmology
  • Mycology
  • Infectious Diseases

Background:

  • Keratomycoses (fungal eye infections) are a growing cause of ocular morbidity, particularly in developing nations.
  • Current antifungal treatments face challenges including poor corneal penetration, fungistatic action, drug resistance, and inadequate sensitivity testing.
  • Limited understanding of synergistic and antagonistic interactions between antifungal agents hinders optimal combination therapy.

Purpose of the Study:

  • To summarize recent advancements in the management of fungal keratitis over the past two years.
  • To provide updated guidelines for treating serious corneal infections caused by fungi.
  • To highlight the importance of early diagnosis and emerging molecular techniques.

Main Methods:

  • Review of recent scientific literature (past 2 years) on fungal keratitis treatment.
  • Analysis of new drug formulations, novel antifungal agents, and innovative drug delivery systems.
  • Discussion of diagnostic advancements, including molecular biological techniques.

Main Results:

  • Encouraging outcomes reported in recent studies for fungal keratitis treatment.
  • Development of improved drug formulations and new antifungal agents.
  • Advancements in drug delivery methods for ocular infections.

Conclusions:

  • Despite challenges, progress in antifungal therapies and drug delivery offers hope for treating fungal keratitis.
  • Early diagnosis and the potential of molecular techniques are crucial for future management.
  • Updated guidelines are essential for effectively managing these severe corneal infections.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...